跳转至内容
Merck
CN

B3936

BAY R3401

≥98% (HPLC), solid

别名:

4-(2-Chlorophenyl)-1-ethyl-2-methyl-5-oxo-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylic acid isopropyl ester

登录并加购,请在购物车里查看协议价、货期和发货地。

选择规格

变更视图

关于此项目

经验公式(希尔记法):
C20H22ClNO4
化学文摘社编号:
分子量:
375.85
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Assay:
≥98% (HPLC)
Form:
solid
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


assay

≥98% (HPLC)

form

solid

color

white

solubility

DMSO: 15 mg/mL

originator

Bayer

storage temp.

2-8°C

SMILES string

CCN1C(C)=C(C(c2ccccc2Cl)C3=C1COC3=O)C(=O)OC(C)C

InChI

1S/C20H22ClNO4/c1-5-22-12(4)16(20(24)26-11(2)3)17(13-8-6-7-9-14(13)21)18-15(22)10-25-19(18)23/h6-9,11,17H,5,10H2,1-4H3

InChI key

NPUSXSOBPNHOPH-UHFFFAOYSA-N

Biochem/physiol Actions

BAY R3401 is a glycogen phosphorylase inhibitor. The racemic prodrug, BAY R3401, suppresses hepatic glycogenolysis. BAY W1807, the active metabolite of BAY R3401, inhibits muscle glycogen phosphorylase a and b. It has been investigated that the metabolites of BAY R3401 suppress hepatic glycogenolysis by allosteric inhibition and dephosphorylation of phosphorylase a.
Glycogen phosphorylase inhibitor.

Features and Benefits

This compound was developed by Bayer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

Light sensitive; store in amber vials.


象形图

Exclamation mark

警示词

Warning

危险代码

Hazard Classifications

Acute Tox. 4 Oral

存储类别

11 - Combustible Solids

怎么回事?

WGK 3

闪点 (F)

Not applicable

闪点 (°C)

Not applicable

PPE(个人防护设备)

dust mask type N95 (US), Eyeshields, Gloves



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库